GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab ; day:12 ; month:5 ; year:2016 ; pages:1-12
Osteoporosis international ; (12.5.2016), 1-12
- Creator
-
Hadji, P.
- Contributor
-
Kybernētakēs, Iōannēs
Kann, P. H.
Niedhart, C.
Hofbauer, L. C.
Schwarz, H.
Kurth, A. A.
Thomasius, F.
Schulte, M.
Intorcia, M.
Psachoulia, E.
Schmid, T.
SpringerLink (Online service)
- DOI
-
10.1007/s00198-016-3623-6
- URN
-
urn:nbn:de:1111-2016051727172
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hadji, P.
- Kybernētakēs, Iōannēs
- Kann, P. H.
- Niedhart, C.
- Hofbauer, L. C.
- Schwarz, H.
- Kurth, A. A.
- Thomasius, F.
- Schulte, M.
- Intorcia, M.
- Psachoulia, E.
- Schmid, T.
- SpringerLink (Online service)
Other Objects (12)
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
A reappraisal of generic bisphosphonates in osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
A reappraisal of generic bisphosphonates in osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Treatment of osteoporosis with denosumab in patients with decreased kidney function